We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -10.00 | -0.68% | 1,455.50 | 1,455.00 | 1,455.50 | 1,468.50 | 1,455.00 | 1,463.00 | 431,915 | 10:32:27 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 31.38B | 2.58B | 0.6212 | 23.49 | 60.75B |
TIDMGSK
RNS Number : 1466P
GlaxoSmithKline PLC
14 October 2021
GlaxoSmithKline plc (the ' Company ')
Transaction notification
Hot Features
Premium
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Ms E Walmsley
==== ====================================== =================================================
b) Position/status Chief Executive Officer
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 October 2021
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP14.2746 2,865.594
===================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2021-10-12
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Mr R Connor
==== ====================================== =================================================
b) Position/status President, Vaccines & Global Health
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 October 2021
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP14.2746 2,809.310
===================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2021-10-12
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Ms D Conrad
==== ====================================== =================================================
b) Position/status SVP, Human Resources
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 October 2021
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP14.2746 9.283
===================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2021-10-12
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Mr J Ford
==== ====================================== =================================================
b) Position/status SVP & General Counsel
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 October 2021
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP14.2746 0.00003
===================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2021-10-12
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Ms S Jackson
==== ====================================== =================================================
b) Position/status SVP, Global Communications and CEO Office
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 October 2021
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP14.2746 359.622
===================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2021-10-12
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Mr D Jackson
==== ====================================== ======================================================
b) Position/status PCA of Ms S Jackson ( SVP, Global Communications
and CEO Office)
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ======================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 October 2021
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP14.2746 168.283
======================================================================= ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
==================================================================== =============================
e) Date of the transaction 2021-10-12
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Mr L Miels
==== ====================================== =================================================
b) Position/status Chief Commercial Officer
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 October 2021
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP14.2746 5,078.983
===================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2021-10-12
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Mr D Redfern
==== ====================================== =================================================
b) Position/status Chief Strategy Officer
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 October 2021
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP14.2746 4,627.648
===================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2021-10-12
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Mr R Simard
==== ====================================== =================================================
b) Position/status President, Pharmaceuticals Supply Chain
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 October 2021
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP14.2746 826.604
===================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2021-10-12
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Mr P Thomson
==== ====================================== =================================================
b) Position/status President, Global Affairs
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 October 2021
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP14.2746 1,002.520
===================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2021-10-12
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Ms K Thomson
==== ====================================== =================================================
b) Position/status PCA of Mr P Thomson (President, Global
Affairs)
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 October 2021
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP14.2746 157.681
===================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2021-10-12
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Ms D Waterhouse
==== ====================================== =================================================
b) Position/status Chief Executive Officer of ViiV Healthcare
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 October 2021
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP14.2746 201.857
===================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2021-10-12
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEZLFFFBLLFBD
(END) Dow Jones Newswires
October 14, 2021 11:28 ET (15:28 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
